A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight
Clinical trial NCT05649137 · COMPLETED
Trial details
- NCT number
- NCT05649137
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-04
- Primary completion
- 2024-10-28
- Enrollment
- 512
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.